US Patent 11433066 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Edenbridge Pharmaceuticals

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Edenbridge Pharmaceuticals

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 8 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
8 News #PharmaBuzz

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

29 FDF Dossiers, 27 FDA Orange Book, 2 Listed Dossiers

29 FDF Dossiers
27 FDA Orange Book
2 Listed Dossiers

INSPECTIONS & REGISTRATIONS

1 FDA

1 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5EDENBRIDGE PHARMS

filter Patent Number Reset all filters

5 All

01 511433066

API Patent Reset all filters

5 All

01 5Blank

FDF Patent Reset all filters

5 All

01 5Blank

filter Expiration Date Reset all filters

5 All

01 52032-09-18

01

EDENBRIDGE PHARMS

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

EDENBRIDGE PHARMS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-18

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 11433066

Drug Substance Claim :

Drug Product Claim :

Application Number : 204242

Patent Use Code : U-3131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDENBRIDGE PHARMS

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

EDENBRIDGE PHARMS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-18

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 11433066

Drug Substance Claim :

Drug Product Claim :

Application Number : 204242

Patent Use Code : U-3131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDENBRIDGE PHARMS

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

EDENBRIDGE PHARMS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-18

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 11433066

Drug Substance Claim :

Drug Product Claim :

Application Number : 204242

Patent Use Code : U-3131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDENBRIDGE PHARMS

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

EDENBRIDGE PHARMS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-18

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 11433066

Drug Substance Claim :

Drug Product Claim :

Application Number : 204242

Patent Use Code : U-3131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

EDENBRIDGE PHARMS

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

BioProcess International US West

Not Confirmed

EDENBRIDGE PHARMS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-18

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 11433066

Drug Substance Claim :

Drug Product Claim :

Application Number : 204242

Patent Use Code : U-3131

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.